Quantitative insulin sensitivity check index
The Quantitative Insulin Sensitivity Check Index (QUICKI) is a mathematical formula utilized to assess insulin sensitivity, a key parameter in the understanding of diabetes and other metabolic disorders. Derived from fasting insulin and fasting glucose levels, QUICKI provides insights into an individual's insulin resistance (IR) and insulin sensitivity (IS).
Formula[edit | edit source]
The QUICKI is calculated using the following equation:
- 1 / (log(fasting insulin μU/mL) + log(fasting glucose mg/dL))
This formula provides an inverse correlation to insulin resistance, meaning a higher QUICKI value indicates greater insulin sensitivity.
Comparison with Other Methods[edit | edit source]
The QUICKI's correlation with the gold standard glucose clamp technique is notably high (r = 0.78), making it a reliable method for insulin sensitivity measurement. The glucose clamp technique is an invasive procedure that directly measures insulin sensitivity, while QUICKI is a less invasive alternative derived from fasting blood values.
Advantages and Applications[edit | edit source]
One of the primary benefits of the QUICKI is its simplicity and the ease with which it can be calculated from just a fasting blood sample. This makes it especially advantageous in clinical research settings where the glucose clamp technique might be impractical or infeasible.
Furthermore, the QUICKI has proven to be a valuable tool for researchers and clinicians aiming to understand the pathophysiology of conditions linked to insulin resistance, such as type 2 diabetes, metabolic syndrome, and certain cardiovascular diseases.
Conclusion[edit | edit source]
The Quantitative Insulin Sensitivity Check Index (QUICKI) offers a simple yet effective method for assessing insulin sensitivity. Due to its close correlation with more invasive methods and its ease of calculation, it has gained favor in various clinical research scenarios.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD